J&J Buys Russian Cold Drug Brands For $260M
Johnson & Johnson kept up its vigorous buying spree Monday, announcing that its Swiss-based Cilag GmbH International unit is buying several leading cough and cold medicine brands in Russia from Mumbai-based...To view the full article, register now.
Already a subscriber? Click here to view full article